Farmaceutica Remedia (BSE:RMAH) EV-to-Revenue : 0.04 (As of Sep. 25, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Farmaceutica Remedia EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Farmaceutica Remedia's enterprise value is lei25.0 Mil. Farmaceutica Remedia's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was lei664.1 Mil. Therefore, Farmaceutica Remedia's EV-to-Revenue for today is 0.04.

The historical rank and industry rank for Farmaceutica Remedia's EV-to-Revenue or its related term are showing as below:

BSE:RMAH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.01 Med: 0.07 Max: 0.44
Current: 0.04

During the past 13 years, the highest EV-to-Revenue of Farmaceutica Remedia was 0.44. The lowest was 0.01. And the median was 0.07.

BSE:RMAH's EV-to-Revenue is ranked better than
95.15% of 103 companies
in the Medical Distribution industry
Industry Median: 0.68 vs BSE:RMAH: 0.04

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-09-25), Farmaceutica Remedia's stock price is lei0.74. Farmaceutica Remedia's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was lei6.53. Therefore, Farmaceutica Remedia's PS Ratio for today is 0.11.

Farmaceutica Remedia EV-to-Revenue Historical Data

The historical data trend for Farmaceutica Remedia's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Farmaceutica Remedia EV-to-Revenue Chart

Farmaceutica Remedia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

0.07

0.08

0.09

0.07

0.05

Farmaceutica Remedia Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EV-to-Revenue	Get a 7-Day Free Trial															0.05	0.07	0.05	0.03	0.04

Competitive Comparison of Farmaceutica Remedia's EV-to-Revenue

For the Medical Distribution subindustry, Farmaceutica Remedia's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farmaceutica Remedia's EV-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Farmaceutica Remedia's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Farmaceutica Remedia's EV-to-Revenue falls into.

Farmaceutica Remedia EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Farmaceutica Remedia's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	25.045	/	664.143
	=	0.04

Farmaceutica Remedia's current Enterprise Value is lei25.0 Mil.
Farmaceutica Remedia's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was lei664.1 Mil.

Farmaceutica Remedia (BSE:RMAH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Farmaceutica Remedia's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.74	/	6.525
	=	0.11

Farmaceutica Remedia's share price for today is lei0.74.
Farmaceutica Remedia's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was lei6.53.

Farmaceutica Remedia EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Farmaceutica Remedia's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Farmaceutica Remedia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Farmaceutica Remedia SA (BSE:RMAH) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040

Website

https://corporate.remedia.ro

Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.

Farmaceutica Remedia Headlines

No Headlines